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Abstract
Background: Early infant diagnosis (EID) of HIV is a key-point for the implementation of early HAART, associated with lower
mortality in HIV-infected infants. We evaluated the EID process of HIV according to national recommendations, in urban
areas of Cameroon.
Methods/Findings: The ANRS12140-Pediacam study is a multisite cohort in which infants born to HIV-infected mothers
were included before the 8
th day of life and followed. Collection of samples for HIV DNA/RNA-PCR was planned at 6 weeks
together with routine vaccination. The HIV test result was expected to be available at 10 weeks. A positive or indeterminate
test result was confirmed by a second test on a different sample. Systematic HAART was offered to HIV-infected infants
identified. The EID process was considered complete if infants were tested and HIV results provided to mothers/family
before 7 months of age. During 2007–2009, 1587 mother-infant pairs were included in three referral hospitals; most infants
(n=1423, 89.7%) were tested for HIV, at a median age of 1.5 months (IQR, 1.4–1.6). Among them, 51 (3.6%) were HIV-
infected. Overall, 1331 (83.9%) completed the process by returning for the result before 7 months (median age: 2.5 months
(IQR, 2.4–3.0)). Incomplete process, that is test not performed, or result of test not provided or provided late to the family,
was independently associated with late HIV diagnosis during pregnancy (adjusted odds ratio (aOR)=1.8, 95%CI: 1.1 to 2.9,
p=0.01), absence of PMTCT prophylaxis (aOR=2.4, 95%CI: 1.4 to 4.3, p=0.002), and emergency caesarean section
(aOR=2.5, 95%CI: 1.5 to 4.3, p=0.001).
Conclusions: In urban areas of Cameroon, HIV-infected women diagnosed sufficiently early during pregnancy opt to benefit
from EID whatever their socio-economic, marital or disclosure status. Reduction of non optimal diagnosis process should
focus on women with late HIV diagnosis during pregnancy especially if they did not receive any PMTCT, or if complications
occurred at delivery.
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Introduction
By the end of 2009, an estimated 2.5 million children worldwide
were living with HIV, mostly a consequence of vertical
transmission, and more than 90% of these children are in sub-
Saharan Africa [1]. In resource limited countries, about 35% of
HIV infected infants without any therapeutic intervention die
before the age of one year [2]. Observational studies in
industrialized countries and a randomized clinical trial in South
Africa demonstrated that early initiation of HAART in infants
dramatically reduces morbidity and mortality [3–6]. These results
led the World Health Organization (WHO), in 2008, to
recommend systematic early initiation of HAART to all HIV-
infected infants diagnosed within the first year of life, and since
2010, within the first two years of life, irrespective of CD4 count or
WHO clinical stage [7,8]. Thus, early diagnosis of HIV infection
in infants is essential. In 2008, only 15% of HIV-exposed infants
benefited from recommended virological tests within the first two
months of life [9].
Many sub-Saharan African countries are increasingly develop-
ing and scaling up access to early infant HIV virological testing,
particularly using dried blood spots (DBS) [9,10,11] generally
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Cameroon a pilot program of HIV early infant diagnosis, was
launched in 2007 using DBS with clinical sites collecting and
sending samples to two referral laboratories for testing. The main
difficulties encountered were the long delay between blood
collection and the result, the large proportion of parents who
failed to return for their infants’ results and HIV-infected infants
being lost to follow-up [12]. Several studies on PMTCT programs
and clinical cohorts throughout sub-Saharan Africa similarly
experienced high rates of loss to follow up [13–15] and some
identified poor socioeconomic conditions as being a cause
[14,16,17]. Despite the investment of financial and human
resources, it remains of primary importance to improve the
acceptability of early HIV testing in infants.
The ANRS 12140-PEDIACAM study started in Cameroon in
November 2007 with two main objectives: to study the feasibility
and effectiveness, in routine practice, of early antiretroviral
multitherapy offered systematically to HIV-infected infants before
7 months of age; and to evaluate the humoral response of these
children to vaccines of the Expanded Program of Immunization
(EPI). All infants born to HIV-infected mothers included in the
Pediacam study were offered early infant diagnosis (EID). Here,
we describe the complete EID process (HIV test performed and
results provided to mothers/family before 7 months of age) in
urban areas of Cameroon and identify maternal and infant
characteristics associated with the EID process being incomplete.
Methods
The ANRS 12140-Pediacam survey
Pediacam is an ongoing prospective observational cohort
coordinated at the Centre Pasteur of Cameroon, and conducted
in three referral hospitals in the two largest cities of Cameroon: the
Central Hospital Maternity (CHM)/Mother and Child Center of
the Chantal Biya Foundation (MCC-CBF), the Hospital Center
Essos (HCE) both in Yaounde and Laquintinie Hospital (LH) in
Douala. These referral hospitals are among the pioneers in the
fight against HIV infection in Cameroon and offer a full range of
services for infant and adult health needs in their areas. The
Pediacam study comprises two consecutive phases. All infants born
live to HIV-infected mothers with documented serostatus were
included before the 8
th day of life in the first phase of the study,
and were followed, tested for HIV and given routine vaccinations
by nurses according to the Cameroonian Expanded Program on
Immunization schedule: BCG and oral polio vaccine at birth,
combination diphtheria, tetanus, pertussis, hepatitis B vaccine and
Haemophilus influenzae type b (Hib) vaccine, oral polio vaccine at 6,
10 and 14 weeks. Prior to inclusion, mothers were provided, by the
physicians involved in the study, with information about the study,
the benefits of follow up and infant testing at 6 weeks, and were
invited to give written informed consent for the participation of
their infant in the study. During the first visit planned at 6 weeks,
early HIV diagnosis was proposed after counselling in addition to
the routine clinical, nutritional and immunization follow up. In the
second phase, systematic HAART and follow up was offered to all
HIV-infected children included in the first phase, and also to HIV-
infected children not followed since birth but aged less than 7
months at diagnosis of HIV infection. Infants born to HIV-
uninfected mothers were also included in a control group. The
ANRS-Pediacam study was granted ethical approval in Cameroon
by the National Ethics Committee and in France by the
Biomedical Research Committee of the Pasteur Institute of Paris.
The Cameroon Ministry of Public Health gave administrative
authorization to start the study.
Study population
This analysis included all infants born live to HIV-infected
mothers enrolled into the first phase of Pediacam from November
2007 to December 2009. They were all aged at least six months at
the time of this analysis.
Process of early infant diagnosis of HIV
Infant follow-up was scheduled to coincide with the Cameroon
National EPI timetable at 6, 10 and 14 weeks thereby limiting the
number of hospital visits. Samples for HIV virological testing were
collected from HIV-exposed infants at the first follow-up visit
planned at 6 weeks of age and the results were expected to be
available at the next visit planned at 10 weeks. The study
physicians and psychosocial workers contributed to post-test
counselling. A positive or indeterminate test result was confirmed
by a second test on a different sample collected as soon as possible
after a phone call to the parents. A second test was also planned for
breastfed infants, six weeks after weaning. In the Pediacam study,
information concerning infant feeding was reported orally by
mothers at inclusion i.e. before the 8
th day of life and during the
first phase follow up visits at 6, 10 and 14 weeks. The central
coordinating team regularly identified infants who did not return
for a follow-up visit within one week of the planned date and
organised with the clinical site to make reminder phone calls.
Incentives, including free medical support for consultation, HIV
diagnosis, additional vaccine (Haemophilus influenzae type b which
was not included in the Expanded Program on Immunization at
the time this project was launched), and reimbursement of taxi
fares were provided to participants by the Pediacam study during
follow-up visits. The project provided free milk as required to
women who choose formula feeding. For infants who tested HIV
negative but were not included in the second phase of the
Pediacam study, clinical follow up was encouraged until at least
the HIV serological test at 15–18 months, in line with the national
recommendations. The EID process from birth to the announce-
ment of the result to the family was considered to be ‘‘complete’’ if
the HIV virological test was performed and the result provided to
mothers/family before 7 months of age.
Virological determination of HIV status
At the first follow-up visit for HIV-exposed infants attending the
Yaounde ´ sites, whole blood was collected into EDTA-containing
anticoagulant tubes and transferred to the Virology Laboratory of
Centre Pasteur of Cameroon. The samples were tested for HIV
RNA by a real-time polymerase chain reaction (RT PCR)
(Biocentric HIV Charge Virale) using the TaqMan technology in
an in-house protocol validated by the French National Agency for
Research on AIDS and Viral Hepatitis [18]. Samples from infants
attending the Douala site were collected onto filter papers (DBS),
processed according to standard procedures [19] and transported to
the National Program Reference laboratory, managed by the US
Center for Disease Control at Mutengene. To reduce the delay
between blood collection and availability of the test result at the
collection site, one of the DBS collected from each infant at the
Douala site was also sent to the Virology Laboratory of Centre
Pasteur of Cameroon. Biocentric HIV DNA cell kit was used to test
for HIV proviral DNA. All samples were also subjected to an in-
house serotyping assay to distinguish between HIV groups and
indirectly confirmed maternal HIV serological status.
Data collection
Data concerning socio-demographic and obstetrical character-
istics, strategies for prevention of mother-to-child transmission,
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treatment, feeding option, and routine immunization were
collected in standardized questionnaires for each mother-child
pair included. Clinical, vaccination and nutrition status was
evaluated at each visit.
Statistical analysis
Characteristics of mother-infant pairs were described using
medians with interquartile ranges (IQR) for continuous variables
and percentages with frequencies for categorical variables. Each
step of the EID process was described, and proportions were
estimated with 95% confidence intervals (95%CI). For multiple
births, only one infant, randomly selected was included in the
statistical analysis. Univariate and multivariate logistic regressions
were performed to identify factors associated with ‘‘incomplete
EID process’’.
A first multivariate logistic regression model included non
collinear variables associated with ‘‘incomplete EID process’’ (as
dependant variable) if the p-value was #0.2 in the univariate
analysis. The final model was obtained using a backward-stepwise
strategy with consideration for confounding effects and interac-
tions. We systematically included the study site and the mother’s
education level. Statistical analyses were performed using STATA
version 10.0 (Stata Corp, College Station, TX, USA). A p-value of
5% was considered for statistical significance of association.
Results
Baseline characteristics of the study population
Between November 2007 and December 2009, 1645 infants
born to 1587 HIV infected mothers at three referral hospitals were
included in the ANRS 12140-Pediacam study: 756 (45.9%) at the
CH/MCC-CBF; 406 (24.7%) at the HCE in Yaounde ´ and 483
(29.4%) at the LH in Douala. Before pregnancy, 666 (42.0%) of
the 1587 mothers were aware of their HIV infection. The median
age of mothers at delivery was 29.2 years (IQR, 25.8–32.8).
Among the mothers, 89.2% delivered vaginally, 3.5% had
multiple births (52 twins and four triplets; one infant each died
at delivery in the case of two twins), 9.9% did not take any
prophylaxis for PMTCT, and 10.7% declared breastfeeding
exclusively. Of the mother-infant pairs enrolled, 1176 (74.1%)
mothers delivered in maternities participating in the study, 392
(24.7%) in other maternities, most of which were located in the
same cities as the referral hospitals, and 19 (1.2%) at home or on
their way to health facilities to deliver. The median age at
enrolment of the HIV-exposed infants was 3 days (IQR, 1–5) and
51.8% were male. The median birth weight was 3150 g (IQR,
2800–3500).
Early infant diagnosis process
Of the 1587 mother-infant pairs, 90.2% (1431) attended at least
one scheduled follow-up visit. Only 0.6% (8) of the infants were
not tested, although the mothers agreed to HIV testing during the
consultation. The mothers of 94.9% (1351) of 1423 infants tested
returned to collect the result: 75.3% (1018) received the result at or
before the infant was 3 months old; 23.2% (313) between ages 4
and 6 months; and only 1.5% (20) were tested and learned about
their HIV result after 6 months of age. The median age at HIV
testing was 1.5 months (IQR, 1.4–1.6), with no significant
differences observed between the sites, and at delivery of the
result was 2.5 months (IQR, 2.4–3.0). The median time between
HIV testing and receipt of the test result was 1.1 month (IQR, 1.0–
1.2) with statistically significant difference according to site of
inclusion (1.0 month for CH/MCC-CBF, 1.0 month for HCE and
1.5 month for LH ; p,10
23). HIV infection was diagnosed in
3.7% (95%CI: 2.8–4.8, n=50) of infants whose family returned to
collect result. Of the 5.1% (n=72) of infants whose parents did not
return to learn about their HIV result, only one had a positive
HIV PCR result, and had died before the test result could be
returned.
Overall, the EID process was incomplete for 16.1% (95%CI:
14.4–18.0; n=256) of the 1587 HIV-exposed infants: these infants
were either not tested or their families did not return to collect the
HIV results before 7 months of age (Fig. 1). The vital status of
infants who did not return for a follow-up visit was determined by
phone calls in 87 cases: 25 died before HIV testing or collection of
results, including 14 deaths before the first visit scheduled before 7
weeks of age. Of the parents of the 62 remaining infants, 45 gave
various reasons to justify their failure to attend the follow up or to
collect the HIV result. Over half (57.8%) reported moving and in
11.1%, the mothers were sick. Other reasons included refusal of
HIV testing, fear of the HIV test results, forgetting about the
follow up visit, the time required for the consultation, attending
follow up in another health structure, and death of a parent. For
149 infants, no information could be obtained concerning the vital
status because they could not be traced mostly due to missing or
incorrect contact information (Fig. 1). These infants were
considered to be lost to follow up.
Factors associated with incomplete early infant diagnosis
process
In univariate analysis, ‘‘incomplete EID process’’ was signifi-
cantly associated with late HIV diagnosis during pregnancy (less
than 3 months before delivery), few antenatal visits (less than 4
visits), absence of MTCT prophylaxis, emergency caesarean
section for delivery, low mother educational level, the lack of a
functional refrigerator, and non disclosure of maternal HIV status
to the partner (Table S1). ‘‘Incomplete EID process’’ also tended
to be more frequent among cases of premature delivery (less than
37 weeks of pregnancy, p=0.09), multiple birth (p=0.07) and
infant hospitalisation at birth (p=0.07).
In multivariate analysis (Table 1), ‘‘incomplete EID process’’
remained independently associated with late HIV diagnosis during
pregnancy (adjusted odds ratio (aOR): 1.8; 95%CI: 1.1 to 2.9;
p=0.01), absence of MTCT prophylaxis (aOR: 2.4; 95%CI: 1.4
to 4.3; p=0.002), and emergency caesarean section (aOR: 2.5,
95%CI: 1.5 to 4.3; p=0.001). Multiple birth tended to be
associated (aOR =1.8, 95%CI: 0.9 to 3.7, p=0.10). None of low
mother’s education level, the lack of a functional fridge, non
disclosure of HIV status to partner, or few antenatal visits were
associated with ‘‘incomplete EID process’’.
Discussion
Early infant diagnosis of HIV is one of the most important
challenges in the management of paediatric HIV infection in
resource limited settings. Here, we describe each step and
obstacles to EID in infants included in the ANRS 12140-
PEDIACAM study. This study involves a large prospective cohort
mainly designed to evaluate the feasibility of early HAART for
HIV-infected infants at three reference hospitals in the two main
cities in Cameroon. As far as we are aware, this is one of the first
large prospective studies to identify factors associated with the
process of infant HIV diagnosis being incomplete in African
settings where early virological testing and antiretroviral drugs are
now available for infants outside of the research context.
In this study, the EID process from birth to the announcement
of the result to the family was considered as complete if the HIV
Feasibility of Early Infant Diagnosis of HIV
PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e21840result was provided to the family before the infant was 7 months
old. Learning the HIV status of the child after age 6 months is too
late to allow early initiation of HAART, in accordance with
several studies [3,5]. This would therefore result in a missed
opportunity for HIV infected infants. Thus, the Pediacam study
recommends starting treatment before age 7 months for all infants
diagnosed as HIV-infected in the first phase of the study.
In the Pediacam study, 90.2% of infants returned at least once
for follow up and almost all were tested for HIV. The return rate
was higher than those previously reported in Malawi [14] and
Uganda [20] where 70% (1503/2156) and 52% (292/567) of HIV
exposed infants, respectively, were brought back for follow up.
However, antiretroviral drugs were not easily accessible to
children at the time of these previous surveys. Our active tracing
method with multiple reminder calls may also explain the higher
rate of return in our study.
Overall, the EID process was complete for 83.9% (95%CI:
82.0–85.6) of infants before the age of 7 months. This rate is
similar to that reported in one clinical setting in Botswana (81%;
753/930) [11], but higher than those in surveys conducted in
Tanzania and in South Africa where 55% (242/441) [21] and
65% (153/233) [22], respectively, of parents/guardians returned
to learn about the results. However, age at diagnosis in these
studies was more diverse: between 1 and 17 months. In the
Pediacam study, the median age at collection of the HIV result
was 2.5 months (IQR, 2.4–3.0). This is satisfactory in relation to
promoting very wide access to HAART before 6 months of age.
Initiating HAART at 3 months, as planned in the CHER
randomized trial [4], would be feasible in routine practice for 75%
of the infants in such settings.
Of every 100 infants offered early testing, 10 did not return for
the test and six were tested but the family did not return to collect
the result before the age of 7 months (both situations being
incomplete EID). We investigated factors associated with incom-
plete EID. Late HIV diagnosis during pregnancy and absence of
prophylaxis for PMTCT were significantly and independently
associated with a higher risk of ‘‘incomplete EID process’’. Loss to
follow up was previously reported to be associated with no
PMTCT prophylaxis in a study in Uganda [20], and with short
time between HIV infection and inclusion in a study for adults in
France [23]. Of the 157 women who did not receive any PMTCT
prophylaxis in Pediacam, 65.0% were diagnosed at a median time
of 3 days (IQR, 1 to 15 days) before delivery (result not showed).
Such a short period does not allow the women time to cope with
the result, to deal with issues around disclosure to partner and to
family, and to appreciate fully the benefits of medical follow up for
both her and her child [24].
Incomplete EID was also significantly and independently
associated with emergency caesarean section. Incomplete EID
also tended to be more frequent in cases of multiple birth, low
birth weight and infant hospitalisation at birth. Multiple birth and
caesarean section were not reported to be associated with loss to
follow up in a study conducted in Malawi [14]. Although our
finding of an association with emergency caesarean section was
unexpected, there are at least two possible explanations. First,
saving the life of the mother and infant is the primary concern in
cases of obstetrical emergency or neonatal complications. In such
situations, prevention of HIV transmission may be a lower
immediate priority for the mother and the medical team, and
there may be little opportunity to discuss the benefits of follow up
and infant HIV testing. Second, complications of labour or
delivery are likely to be one of the reasons to refer women followed
in primary antenatal care setting to the hospitals participating in
the Pediacam survey. These women may prefer to return after
Figure 1. Take-up and key points of early infant HIV diagnosis process (ANRS12140-Pediacam study, Cameroon, 2007–2009).
doi:10.1371/journal.pone.0021840.g001
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Cameroon, 2007–2009).
Initial logistic regression model
Final logistic
regression model
Total (n=1285) adjusted OR (CI 95%)p-value adjusted OR (CI 95%)p-value
Clinical sites 0.25 0.33
EHC* 1.2 (0.8–1.8) 0.44 1.2 (0.8–1.8) 0.44
LH
{ 0.8 (0.5–1.2) 0.28 0.8 (0.5–1.2) 0.32
CHM/MCC-CBF
{ ref ref
Mothers’ level of education 0.50 0.36
None or primary education 1.4 (0.8–2.5) 0.24 1.5 (0.8–2.6) 0.15
Secondary 1.2 (0.8–2.0) 0.40 1.3 (0.8–2.1) 0.29
Higher education ref ref
Presence of a functional fridge at home
No 1.2 (0.8–1.6) 0.33
Yes ref
Time at maternal HIV diagnosis 0.10 0.04
Less than 3 months before delivery 1.7 (1.0–2.7) 0.04 1.8 (1.1–2.9) 0.01
More than 3 months before delivery 1.2 (0.8–1.7) 0.50 1.2 (0.8–1.8) 0.36
Before pregnancy ref ref
Disclosure of maternal HIV serostatus to partner
No 1.3 (0.8–1.9) 0.27
Yes ref
Maternal knowledge of the fathers’ HIV status 0.25
Did not know 1.2 (0.7–1.9) 0.47
Negative 1.4 (0.9–2.2) 0.11
Positive ref
Number of antenatal visits
#3 1.1 (0.7–1.7) 0.72
.3 ref
Mode of delivery 0.005 0.003
Emergency C-section 2.5 (1.4–4.3) 0.001 2.5 (1.5–4.3) 0.001
Elective C-section 0.7 (0.2–2.2) 0.59 0.8 (0.3–2.2) 0.62
Vaginal ref ref
Receipt of any ART for PMTCT 0.02 0.009
No prophylaxis 2.3 (1.2–4.1) 0.005 2.4 (1.4–4.3) 0.002
Short-course combined ARV 1.4 (0.9–2.1) 0.14 1.3 (0.9–2.0) 0.16
Tritherapy ref ref
Birth weight
,2500 g 1.3 (0.7–2.2) 0.38
$2500 g ref
Prematurity
,37 weeks 1.0 (0.6–1.6) 0.92
$37 weeks ref
Multiple birth
Yes 1.5 (0.7–3.4) 0.26 1.8 (0.9–3.7) 0.10
No ref ref
Infant hospitalised at birth
Yes 1.2 (0.7–1.9) 0.57
No ref
*EHC : Essos Hospital Center, Yaounde ´.
{LH : Laquintinie Hospital, Douala.
{CHM / MCC-CBF: Central Hospital Maternity / Mother and Child Center of the Chantal Biya Foundation, Yaounde ´.
doi:10.1371/journal.pone.0021840.t001
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the referral status of pregnant women was not collected in
Pediacam study so it is not possible to test whether or not this was
indeed the case.
Incomplete EID process was also associated, in univariate
analysis, with factors related to living conditions and socio-
economic status: low level of mother education, absence of a
functional fridge at home, and failure to disclose their HIV status
to partner. However, odds ratios were lower for these factors than
for factors related to late HIV diagnosis and obstetrical context of
delivery (Table S1). Moreover, these associations did not remain
significant in multivariate analysis (Table 1). Our results thus
contrast with those of other studies which report a higher rate of
loss to follow up in poor socioeconomic conditions (low education
level, farming, long distances and cost of transport) [14,25] and in
cases of non disclosure of HIV status [16].
The median time between HIV testing and receipt of test result
differed between Pediacam sites, mainly due to the DBS being
used in one of the sites. More time is needed for preparation,
conditioning and transport of DBS to the laboratory. This did not
affect the completeness of the process within 6 months, but could
do so if the aim was to complete the process in 3 months. This
underlines the importance of carefully evaluating local obstacles to
implementation of an EID programme.
The proportion of mothers initiating formula feeding was higher
than is generally the case nationwide, but was consistent with what
has been described previously in these settings [26,27]. In 2009,
only 32% of HIV-infected mothers reported formula feeding [12].
The infant feeding policy in Cameroon promotes exclusive
breastfeeding for the first six months, unless replacement feeding
is acceptable, feasible, affordable, sustainable and safe. The high
proportion of formula feeding in the Pediacam study may be
explained by the active counselling, by the higher economic status
and lower socio-cultural pressure on feeding practices in urban
areas than in others areas in the country.
This study has some limitations. The inclusion of infants born to
HIV-infected mothers at Pediacam study maternities was not
exhaustive. The failure to return may in some cases have been the
consequence of mortality. However, the vital status could not be
established for 149 of the 256 children with incomplete process
(Fig. 1). The mortality rate during the process, estimated among
the 1438 infants with known vital status, was 17.4 per 1000 live
births (95%CI: 11.3–25.6, n=25), which is lower than the
estimated national rate in Cameroon: 29% in the first month
[28]. This lower rate may have been due to better early clinical
management. The value, however, may also reflect a high rate of
early mortality among the infants who never returned, possibly
due to severe HIV infection. Indeed, continuing this argument
would suggest that the transmission rate for HIV of 3.6% (2.8 –
4.8) may be an underestimation.
Despite these limitations, one of the strengths of Pediacam study
was that it was conducted in three centres in two large cities of
Cameroon. These centres have very different working practices
and recruitments so the study reflects the diversity of practical
management of EID in a heterogeneous population mostly living
in urban areas.
In summary, our study shows good take-up of EID services and
high proportion of mothers returning to collect their infant’s result
within the first six months of life in an operational setting. As
nearly half of the mothers knew their HIV status before
pregnancy, most of them were likely to have knowledge of the
benefits of PMTCT, and infant HIV diagnosis and follow up. In
the Pediacam study, the risk factors for ‘‘incomplete EID process’’
reflected the quality of prenatal care and the obstetrical context
(late HIV diagnosis, lack of any prophylaxis for PMTCT,
emergency caesarean section), rather than environmental condi-
tions such as socio-economic, marital and disclosure status. This
may be partly due to the follow-up schedule being tied to the
national vaccination programme, and partly to incentives and
active reminders by telephone calls.
It seems to be very important to focus on women diagnosed at,
or only a few days before, delivery, especially if they did not
receive any PMTCT, or if they were transferred from their usual
care setting for emergency delivery. All maternity team members
should be aware of these issues, so as to offer reinforced support
just after delivery in these situations at risk of non optimal follow
up of the infant.
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